海辰药业
(300584)
| 流通市值：14.80亿 | | | 总市值：21.62亿 |
| 流通股本：8211.86万 | | | 总股本：1.20亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 19,874,244.44 | 46,822,088.15 | 72,442,103.38 | 93,454,415.39 |
| 应收票据及应收账款 | 200,965,069.16 | 206,779,467.11 | 176,789,675.51 | 180,364,692.21 |
| 应收账款 | 200,965,069.16 | 206,779,467.11 | 176,789,675.51 | 180,364,692.21 |
| 应收款项融资 | 1,204,558.44 | 918,122.72 | 270,000 | 1,823,542.98 |
| 预付款项 | 3,819,330.69 | 5,783,871.79 | 7,908,950.87 | 11,142,464.01 |
| 其他应收款合计 | 595,961.29 | 125,876.44 | 619,466.98 | 554,953.71 |
| 存货 | 87,529,909.4 | 81,455,425.23 | 78,313,347.14 | 77,743,714.08 |
| 其他流动资产 | 39,452,890.6 | 35,410,977.87 | 30,901,455.56 | 27,957,206.49 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 353,441,964.02 | 377,295,829.31 | 367,244,999.44 | 394,041,482.02 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 131,460,346.88 | 131,460,346.88 | 131,460,346.88 | 131,460,346.88 |
| 投资性房地产 | 15,067,059.43 | 15,330,799.21 | 15,594,538.99 | 15,858,278.77 |
| 固定资产 | 257,986,650.82 | 265,237,821.47 | 272,435,690.76 | 280,767,751.33 |
| 在建工程 | 424,506,623.61 | 381,517,270.03 | 323,247,735.23 | 289,119,840.27 |
| 无形资产 | 130,503,426.57 | 126,765,434.45 | 123,342,090.69 | 124,877,910.4 |
| 开发支出 | 35,982,617.03 | 41,538,702.83 | 48,017,780.95 | 41,955,119.32 |
| 递延所得税资产 | 22,249,213.26 | 21,835,825.44 | 20,469,258.25 | 19,572,753.13 |
| 其他非流动资产 | 40,711,118.7 | 47,882,350.78 | 39,379,741.9 | 23,395,129.8 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,058,467,056.3 | 1,031,568,551.09 | 973,947,183.65 | 927,007,129.9 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,411,909,020.32 | 1,408,864,380.4 | 1,341,192,183.09 | 1,321,048,611.92 |
| 流动负债: | | | | |
| 短期借款 | 252,989,333.1 | 252,982,666.67 | 178,129,274.94 | 157,120,774.96 |
| 应付票据及应付账款 | 62,410,001.89 | 63,947,838.41 | 70,633,534.81 | 71,860,698.89 |
| 其中：应付票据 | 28,654,328.24 | 28,441,786.79 | 48,211,998.23 | 48,705,953.89 |
| 应付账款 | 33,755,673.65 | 35,506,051.62 | 22,421,536.58 | 23,154,745 |
| 合同负债 | 2,905,563.9 | 3,357,792.99 | 987,556.79 | 2,609,809.73 |
| 应付职工薪酬 | 336,811.47 | 4,633,904.31 | 284,595.04 | 269,761.36 |
| 应交税费 | 17,977,107 | 20,055,644.04 | 12,929,248.42 | 11,882,276.2 |
| 其他应付款合计 | 24,307,140.81 | 27,613,990.79 | 30,641,891 | 34,357,610.04 |
| 一年内到期的非流动负债 | 17,565,180.6 | 18,015,555.46 | 43,582,662.53 | 44,037,593.81 |
| 其他流动负债 | 11,059,004.32 | 9,660,813.71 | 7,549,154.92 | 4,167,832.75 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 389,550,143.09 | 400,268,206.38 | 344,737,918.45 | 326,306,357.74 |
| 非流动负债: | | | | |
| 递延收益 | 6,420,418.12 | 6,479,856.64 | 6,859,628.3 | 7,399,566.83 |
| 递延所得税负债 | 15,077,360.42 | 14,620,179.16 | 15,959,912.25 | 17,183,711.91 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 21,497,778.54 | 21,100,035.8 | 22,819,540.55 | 24,583,278.74 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 411,047,921.63 | 421,368,242.18 | 367,557,459 | 350,889,636.48 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 120,000,000 | 120,000,000 | 120,000,000 | 120,000,000 |
| 资本公积 | 210,285,601.01 | 210,285,601.01 | 210,285,601.01 | 210,285,601.01 |
| 专项储备 | 728,534.75 | 721,387.72 | 753,095.2 | 224,852.49 |
| 盈余公积 | 60,000,000 | 60,000,000 | 60,000,000 | 60,000,000 |
| 未分配利润 | 609,846,962.93 | 596,489,149.49 | 582,596,027.88 | 579,648,521.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,000,861,098.69 | 987,496,138.22 | 973,634,724.09 | 970,158,975.44 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,000,861,098.69 | 987,496,138.22 | 973,634,724.09 | 970,158,975.44 |
| 负债和股东权益合计 | 1,411,909,020.32 | 1,408,864,380.4 | 1,341,192,183.09 | 1,321,048,611.92 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-27 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |